Pearl IRB is pleased to launch it’s whitepaper entitled “Trends and Insights in IRB Warning Letters.” Learn all about IRB warning letters issued by the FDA, review the issues, and learn how to protect yourself from violations. Click here to download.
Single IRB – A Guide to the Common Rule sIRB Mandate
The sIRB requirement is active. Is your study affected?
Clinical Research Accelerated
You need high quality, timely board reviews so that you can get your study in the clinic.
Recent Posts
Imposter Participants: Fake Participants Causing Real Problems
2025 Holiday Schedule
OHRP’s Proposed Changes to the Federalwide Assurance Form: An Update
The Latest Federal Funding Cuts and Their Impact on Ethical Clinical Research Oversight
Chevron, Natural Resources Defense Council, Loper Bright Enterprises, Raimondo, et al.